Smoking & Vaping Flashcards
1
Q
SMOKING PREVALENCE
A
- 2022; 12.9% people aged 18y+ in UK = current smokers (6.4 million)
- smoking prevalence = highest among 25-34y & is higher on average in men
2
Q
E-CIGARETTES & VAPING
A
- 5.2% people (16y) = currently daily users of e-cigarettes (aka. daily vapers)
- 3.5% = occasional vapers
- 2022; 16-24y = more likely to report daily/occasional vaping than all other ages
3
Q
HEALTH IMPACTS OF SMOKING
A
- 506,100 hospital admissions attributable to smoking; similar to 2018/19 BUT 10% higher than 2009/10 (461,700)
- 74,600 deaths attributable to smoking; decrease of 3% from 2018 (77,000)/9% from 2009 (82,000)
4
Q
SECONDHAND SMOKE EFFECTS
A
- NO safe lvl of exposure to secondhand smoke; adults who DON’T smoke BUT still experience secondhand smoke may have:
1. coronary heart disease
2. stroke
3. lung cancer
4. premature death
5. nasal irritation
6. adverse reproductive health effects (incl. low birth weight) - children may have:
1. sudden infant death syndrome
2. middle ear disease
3. respiratory issues (ie. impaired lung function; lower illness)
5
Q
SECOND/THIRDHAND SMOKE (AKA. AEROSOLS)
A
- secondhand vaping aerosols come from burning/heating tobacco via cigarette/cigar/pipe/hookah/e-cig
- also come from air smoker exhales
- thirdhand smoke stays in carpets/walls/furniture/clothing/hair/toys
- person/car/room continues to smell of smoke long after cig is put out
- both contain harmful/toxic cancer-causing chemicals; can be swallowed (ie. kids put hands/objects in mouths oft)
6
Q
COGNITION “BENEFITS”
A
- (smoking -> nicotine -> cognition)
- Alzherimer’s
- Parkinson’s
- schizophrenia
- depression
- aging
- anxiety
7
Q
COGNITION LIMITATIONS
A
- pregnant exposure
- adolescent exposure
- high-dose exposure
- withdrawal effect
8
Q
CONFOUNDS
A
- cigarette smoke contains many other compounds + nicotine than may have cognitive-enhancing effects
- amount of nicotine delivered via smoking = highly variable & dependent on type of cigarette/how individual smokes
- to avoid such limitations numerous studies on modulation of cognition by nicotine have used pure nicotine administered via nasal spray/transdermal patch/subcutaneous injection/oral inhaler/intravenous infusion
9
Q
NICOTINE
A
- addictive substance
- plays key role in initiating/maintaining tobacco use
- rapid delivery rate to brain (10-20s post puff) likely contributes to rewarding properties
- average terminal half-life of 2h; w/regular dosing blood nicotine lvls rise over 6-8h then plateau
10
Q
NICOTINIC ACETYLCHOLINE RECEPTORS (nAChRs)
A
- nicotine’s primary sites of drug action
- present in brain/throughout body:
1. blood vessels (endothelial cells)
2. epithelial cells
3. inflammatory cells (ie. T-cells; macrophages; astrocytes; microglia) - majority of neuronal nAChRs = excitatory/fast acting (millisecond range)
- activated -> modulate release of other neurotransmitters:
1. acetylcholine (ACh)
2. dopamine (DA)
3. serotonin
4. glutamate
5. GABA
6. norepinephrine
11
Q
SMOKING & CARDIOVASCULAR TOXICITY
A
- cigarette smoke contains > 9k chemicals & > 69 known carcinogens
- most concerning are:
1. oxidising chemicals
2. carbon monoxide
3. volatile organic compounds
4. particulates
5. heavy metals
6. nicotine
12
Q
NICOTINE & CARDIOVASCULAR TOXICITY
A
- nicotine ->
- sympathetic nervous system activation ->
- coronary vasoconstriction OR…
- increased HR/blood pressure/myocardial contractility ->
- increased myocardial demain for oxygen/nutrients ->
- myocardial ischemia/infarction ->
- sudden death
13
Q
CARBON MONOXIDE & CARDIOVASCULAR TOXICITY
A
- carbon monoxide ->
- reduced oxygen availability ->
- reduced myocardial blood/oxygen/nutrient supply & coronary occlusion ->
- myocardial ischemia/infarction ->
- sudden death
14
Q
OXIDANT CHEMICALS & CARDIOVASCULAR TOXICITY
A
- oxidant chemicals/particulares/other combustion products ->
- inflammation ->
- platelet activation/thrombosis & endothelial dysfunction ->
- coronary vasoconstriction & reduced myocardial blood/oxygen/nutrient supply & coronary occlusion ->
- myocardial ischemia/infraction ->
- sudden death
15
Q
NICOTINE & nAChRs
A
- nAChRs = widespread throughout brain (aka. thalamus; basal ganglia; PFC; hippocampus; cerebellum)
- acute effect of smoking = enhancement of neurotransmission through cortico-basal ganglia-thalamic circuits